Works matching Salvinorin A

Results: 165

Bioisosteric Modification of Salvinorin A, a Potent and Selective Kappa-Opioid Receptor Agonist.

Published in:

Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur Medizin und Naturwissenschaften), 2006, v. 56, n. 4, p. 269

By:

Stewart, D. Jeremy;
Fahmy, Hesham;
Roth, Bryan L.;
Feng Yan;
Zjawiony, Jordan K.

Publication type:

Article

Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.

Published in:

Psychopharmacology, 2009, v. 203, n. 2, p. 203, doi. 10.1007/s00213-008-1458-3

By:

Baker, Lisa;
Panos, John;
Killinger, Bryan;
Peet, Mary;
Bell, Lisa;
Haliw, Larissa;
Walker, Sheryl

Publication type:

Article

Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum.

Published in:

Annals of Botany, 2004, v. 93, n. 6, p. 763, doi. 10.1093/aob/mch089

By:

SIEBERT, DANIEL J.

Publication type:

Article

Analyzing Salvia Divinorum and its Active Ingredient Salvinorin A Utilizing Thin Layer Chromatography and Gas Chromatography/Mass Spectrometry.

Published in:

Journal of Forensic Sciences, 2009, v. 54, n. 3, p. 612, doi. 10.1111/j.1556-4029.2009.00999.x

By:

Jermain, John D.;
Evans, Hiram K.

Publication type:

Article

Formal Total Synthesis of Salvinorin A.

Published in:

ChemistryOpen, 2022, v. 11, n. 10, p. 1, doi. 10.1002/open.202200015

By:

Halang, Marc;
Maier, Martin E.

Publication type:

Article

A (-)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum.

Published in:

Journal of Experimental Botany, 2017, v. 68, n. 5, p. 1109, doi. 10.1093/jxb/erw493

By:

Xiaoyue Chen;
Berim, Anna;
Dayan, Franck E.;
Gang, David R.

Publication type:

Article

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Published in:

Frontiers in Pharmacology, 2015, p. 1, doi. 10.3389/fphar.2015.00190

By:

Butelman, Eduardo R.;
Kreek, Mary Jeanne;
Cauli, Omar;
Mavrikaki, Maria

Publication type:

Article

In vitro studies on metabolism of salvinorin A.

Published in:

Pharmaceutical Biology, 2009, v. 47, n. 11, p. 1078, doi. 10.3109/13880200903002222

By:

Kutrzeba, Lukasz M.;
Karamyan, Vardan T.;
Speth, Robert C.;
Williamson, John S.;
Zjawiony, Jordan K.

Publication type:

Article

Simple Preparative Isolation of Salvinorin A from the Hallucinogenic Sage, Salvia divinorum, by Centrifugal Partition Chromatography.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2007, v. 30, n. 8, p. 1105, doi. 10.1080/10826070601128477

By:

Shirota, Osamu;
Nagamatsu, Kumi;
Sekita, Setsuko

Publication type:

Article

The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.

Published in:

Psychopharmacology, 2017, v. 234, n. 16, p. 2499, doi. 10.1007/s00213-017-4637-2

By:

Ewald, Amy;
Bosch, Peter;
Culverhouse, Aimee;
Crowley, Rachel;
Neuenswander, Benjamin;
Prisinzano, Thomas;
Kivell, Bronwyn

Publication type:

Article

Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.

Published in:

Psychopharmacology, 2015, v. 232, n. 1, p. 91, doi. 10.1007/s00213-014-3641-z

By:

Serra, Veronica;
Fattore, Liana;
Scherma, Maria;
Collu, Roberto;
Spano, Maria;
Fratta, Walter;
Fadda, Paola

Publication type:

Article

Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys.

Published in:

Psychopharmacology, 2014, v. 231, n. 14, p. 2751, doi. 10.1007/s00213-014-3436-2

By:

Freeman, Kevin;
Naylor, Jennifer;
Prisinzano, Thomas;
Woolverton, William

Publication type:

Article

Analysis of the Psychoactive Terpenoid Salvinorin A Content in Five Salvia divinorum Herbal Products.

Published in:

Pharmacotherapy, 2006, v. 26, n. 9, p. 1268, doi. 10.1592/phco.26.9.1268

By:

Wolowich, William R.;
Perkins, Alisha M.;
Cienki, John J.

Publication type:

Article

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.

Published in:

International Journal of Neuropsychopharmacology, 2016, v. 19, n. 7, p. 1, doi. 10.1093/ijnp/pyw016

By:

Elda Maqueda, Ana;
Valle, Marta;
Addy, Peter H.;
Maria Antonijoan, Rosa;
Puntes, Montserrat;
Coimbra, Jimena;
Rosa Ballester, Maria;
Garrido, Maite;
González, Mireia;
Claramunt, Judit;
Barker, Steven;
Lomnicka, Izabela;
Waguespack, Marian;
Johnson, Matthew W.;
Griffiths, Roland R.;
Riba, Jordi

Publication type:

Article

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.

Published in:

International Journal of Neuropsychopharmacology, 2015, v. 18, n. 12, p. 1, doi. 10.1093/ijnp/pyv065

By:

Elda Maqueda, Ana;
Valle, Marta;
Addy, Peter H.;
Antonijoan, Rosa Maria;
Puntes, Montserrat;
Coimbra, Jimena;
Rosa Ballester, Maria;
Garrido, Maite;
González, Mireia;
Claramunt, Judit;
Barker, Steven;
Johnson, Matthew W.;
Griffiths, Roland R.;
Riba, Jordi

Publication type:

Article

Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs.

Published in:

Frontiers in Psychiatry, 2019, p. N.PAG, doi. 10.3389/fpsyt.2019.00157

By:

Zjawiony, Jordan K.;
Machado, Antônio S.;
Menegatti, Ricardo;
Ghedini, Paulo C.;
Costa, Elson A.;
Pedrino, Gustavo R.;
Lukas, Scott E.;
Franco, Octávio L.;
Silva, Osmar N.;
Fajemiroye, James O.

Publication type:

Article

Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.

Published in:

2008

By:

Capasso, R.;
Borrelli, F.;
Cascio, M. G.;
Aviello, G.;
Huben, K.;
Zjawiony, J. K.;
Marini, P.;
Romano, B.;
Di Marzo, V.;
Capasso, F.;
Izzo, A. A.

Publication type:

journal article

An Overview of Syntheses of Salvinorin A and its Analogues.

Published in:

ChemCatChem, 2024, v. 16, n. 16, p. 1, doi. 10.1002/cctc.202400182

By:

Tibouti, Soufian;
Barriault, Louis

Publication type:

Article

Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.

Published in:

2016

By:

Johnson, Matthew W.;
MacLean, Katherine A.;
Caspers, Michael J.;
Prisinzano, Thomas E.;
Griffiths, Roland R.

Publication type:

journal article

Salvinorin A inhibits ovalbumin‐stimulated allergic rhinitis and RBL‐2H3 cells degranulation.

Published in:

FEBS Open Bio, 2021, v. 11, n. 8, p. 2166, doi. 10.1002/2211-5463.13219

By:

Shou, Qiyang;
Tan, Tao;
Xu, Faying

Publication type:

Article

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.

Published in:

Molecules, 2023, v. 28, n. 12, p. 4848, doi. 10.3390/molecules28124848

By:

van de Wetering, Ross;
Ewald, Amy;
Welsh, Susan;
Kornberger, Lindsay;
Williamson, Samuel E.;
McElroy, Bryan D.;
Butelman, Eduardo R.;
Prisinzano, Thomas E.;
Kivell, Bronwyn M.

Publication type:

Article

Salvinorin A Does Not Affect Seizure Threshold in Mice.

Published in:

Molecules, 2020, v. 25, n. 5, p. 1204, doi. 10.3390/molecules25051204

By:

Socała, Katarzyna;
Doboszewska, Urszula;
Wlaź, Piotr

Publication type:

Article

An immunochromatographic assay for rapid etection of salvinorin A.

Published in:

Journal of Immunoassay & Immunochemistry, 2017, v. 38, n. 4, p. 438, doi. 10.1080/15321819.2017.1324797

By:

Paudel, Madan Kumar;
Shirota, Osamu;
Sakamoto, Seiichi;
Morimoto, Satoshi;
Tanaka, Hiroyuki

Publication type:

Article

A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.

Published in:

Journal of Computer-Aided Molecular Design, 2006, v. 20, n. 7/8, p. 1, doi. 10.1007/s10822-006-9067-x

By:

Singh, Nidhi;
Chevé, Gwénaël;
Ferguson, David M.;
McCurdy, Christopher R.

Publication type:

Article

Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

Published in:

Psychopharmacology, 2013, v. 226, n. 2, p. 381, doi. 10.1007/s00213-012-2912-9

By:

MacLean, Katherine;
Johnson, Matthew;
Reissig, Chad;
Prisinzano, Thomas;
Griffiths, Roland

Publication type:

Article

Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum.

Published in:

Psychopharmacology, 2008, v. 197, n. 3, p. 509, doi. 10.1007/s00213-007-1067-6

By:

Gehrke, Brenda J.;
Chefer, Vladimir I.;
Shippenberg, Toni S.

Publication type:

Article

Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.

Published in:

Psychopharmacology, 2005, v. 179, n. 3, p. 551, doi. 10.1007/s00213-004-2087-0

By:

Yong Zhang;
Butelman, Eduardo R.;
Schlussman, Stefan D.;
Ho, Ann;
Kreek, Mary Jeanne

Publication type:

Article

The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys.

Published in:

Psychopharmacology, 2004, v. 172, n. 2, p. 220, doi. 10.1007/s00213-003-1638-0

By:

Butelman, Eduardo R.;
Harris, Todd J.;
Kreek, Mary Jeanne

Publication type:

Article

Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 12, p. 1619, doi. 10.3390/ph17121619

By:

Quiñonez-Bastidas, Geovanna Nallely;
Grijalva-Contreras, Lucia Elhy;
Patiño-Camacho, Selene Isabel;
Navarrete, Andrés

Publication type:

Article

A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist.

Published in:

FEBS Journal, 2006, v. 273, n. 9, p. 1966, doi. 10.1111/j.1742-4658.2006.05212.x

By:

Kane, Brian E.;
Nieto, Marcelo J.;
McCurdy, Christopher R.;
Ferguson, David M.

Publication type:

Article

Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization.

Published in:

Frontiers in Pharmacology, 2017, v. 7, p. 1, doi. 10.3389/fphar.2016.00525

By:

Rossi, Antonietta;
Caiazzo, Elisabetta;
Bilancia, Rossella;
Riemma, Maria A.;
Pagano, Ester;
Cicala, Carla;
Ialenti, Armando;
Zjawiony, Jordan K.;
Izzo, Angelo A.;
Capasso, Raffaele;
Roviezzo, Fiorentina

Publication type:

Article

Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ-opioid and cannabinoid receptors.

Published in:

Neurogastroenterology & Motility, 2009, v. 21, n. 12, p. 1326, doi. 10.1111/j.1365-2982.2009.01369.x

By:

FICHNA, J.;
SCHICHO, R.;
ANDREWS, C. N.;
BASHASHATI, M.;
KLOMPUS, M.;
MCKAY, D. M.;
SHARKEY, K. A.;
ZJAWIONY, J. K.;
JANECKA, A.;
STORR, M. A.

Publication type:

Article

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.

Published in:

Neurogastroenterology & Motility, 2008, v. 20, n. 2, p. 142, doi. 10.1111/j.1365-2982.2007.00994.x

By:

Capasso, R.;
Borrelli, F.;
Zjawiony, J.;
Kutrzeba, L.;
Aviello, G.;
Sarnelli, G.;
Capasso, F.;
Izzo, A. A.

Publication type:

Article

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.

Published in:

Neurogastroenterology & Motility, 2006, v. 18, n. 1, p. 69, doi. 10.1111/j.1365-2982.2005.00725.x

By:

Capasso, R.;
Borrelli, F.;
Capasso, F.;
Siebert, D. J.;
Stewart, D. J.;
Zjawiony, J. K.;
Izzo, A. A.

Publication type:

Article

In vitro stability and metabolism of salvinorin A in rat plasma.

Published in:

Xenobiotica, 2009, v. 39, n. 5, p. 391, doi. 10.1080/00498250902769967

By:

Tsujikawa, K.;
Kuwayama, K.;
Miyaguchi, H.;
Kanamori, T.;
Iwata, Y. T.;
Inoue, H.

Publication type:

Article

Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo.

Published in:

Journal of Molecular Medicine, 2011, v. 89, n. 9, p. 891, doi. 10.1007/s00109-011-0752-4

By:

Aviello, Gabriella;
Borrelli, Francesca;
Guida, Francesca;
Romano, Barbara;
Lewellyn, Kevin;
De Chiaro, Maria;
Luongo, Livio;
Zjawiony, Jordan K.;
Maione, Sabatino;
Izzo, Angelo A.;
Capasso, Raffaele

Publication type:

Article

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Published in:

2015

By:

Butelman, Eduardo R.;
Kreek, Mary Jeanne;
Panagis, George

Publication type:

Correction Notice

Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor.

Published in:

Molecules, 2023, v. 28, n. 2, p. 718, doi. 10.3390/molecules28020718

By:

Puls, Kristina;
Wolber, Gerhard

Publication type:

Article

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Published in:

Molecules, 2018, v. 23, n. 10, p. 2602, doi. 10.3390/molecules23102602

By:

Kivell, Bronwyn M.;
Paton, Kelly F.;
Kumar, Nitin;
Morani, Aashish S.;
Culverhouse, Aimee;
Shepherd, Amy;
Welsh, Susan A.;
Biggerstaff, Andrew;
Crowley, Rachel S.;
Prisinzano, Thomas E.

Publication type:

Article

Acute and post-acute behavioral and psychological effects of salvinorin A in humans.

Published in:

Psychopharmacology, 2012, v. 220, n. 1, p. 195, doi. 10.1007/s00213-011-2470-6

By:

Addy, Peter

Publication type:

Article

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.

Published in:

Psychopharmacology, 2011, v. 214, n. 4, p. 933, doi. 10.1007/s00213-010-2103-5

By:

Mendelson, John;
Coyle, Jeremy;
Lopez, Juan;
Baggott, Matthew;
Flower, Keith;
Everhart, E.;
Munro, Thomas;
Galloway, Gantt;
Cohen, Bruce

Publication type:

Article

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain.

Published in:

Frontiers in Neuroscience, 2020, v. 14, p. 1, doi. 10.3389/fnins.2020.00765

By:

Paton, Kelly F.;
Biggerstaff, Andrew;
Kaska, Sophia;
Crowley, Rachel S.;
La Flamme, Anne C.;
Prisinzano, Thomas E.;
Kivell, Bronwyn M.

Publication type:

Article

Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection.

Published in:

Molecular Pain, 2012, v. 8, n. 1, p. 60, doi. 10.1186/1744-8069-8-60

By:

Guida, Francesca;
Luongo, Livio;
Aviello, Gabriella;
Palazzo, Enza;
De Chiaro, Maria;
Gatta, Luisa;
Boccella, Serena;
Marabese, Ida;
Zjawiony, Jordan K.;
Capasso, Raffaele;
Izzo, Angela A.;
de Novellis, Vito;
Maione, Sabatino

Publication type:

Article

The influence of cultivation conditions on the formation of psychoactive salvinorin A, salvinorin B, rosmarinic acid and caffeic acid in Coleus scutellarioides.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57399-y

By:

Jakobina, Maciej;
Łyczko, Jacek;
Szumny, Antoni;
Galek, Renata

Publication type:

Article

A Protecting‐Group‐Free Synthesis of (−)‐Salvinorin A.

Published in:

Chemistry - A European Journal, 2021, v. 27, n. 29, p. 7968, doi. 10.1002/chem.202100560

By:

Zimdars, Patrick;
Wang, Yuzhou;
Metz, Peter

Publication type:

Article

Identification of clerodane diterpene modifying cytochrome P450 (CYP728D26) in Salvia divinorum ‐ en route to psychotropic salvinorin A biosynthesis.

Published in:

Physiologia Plantarum, 2024, v. 176, n. 5, p. 1, doi. 10.1111/ppl.14569

By:

Ngo, Iris;
Kumar, Rahul;
Li, Liang;
Kim, Seon‐Won;
Kwon, Moonhyuk;
Ro, Dae‐Kyun

Publication type:

Article

Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.

Published in:

Neuropsychopharmacology, 2015, v. 40, n. 13, p. 2865, doi. 10.1038/npp.2015.159

By:

Placzek, Michael S;
Van de Bittner, Genevieve C;
Wey, Hsiao-Ying;
Lukas, Scott E;
Hooker, Jacob M

Publication type:

Article

Metabolic Changes in the Rodent Brain after Acute Administration of Salvinorin A.

Published in:

Molecular Imaging & Biology, 2009, v. 11, n. 3, p. 137, doi. 10.1007/s11307-008-0192-x

By:

Jacob Hooker;
Vinal Patel;
Shiva Kothari;
Wynne Schiffer

Publication type:

Article

Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB<sub>1</sub>-cannabinoid receptor involvement.

Published in:

Psychopharmacology, 2007, v. 190, n. 4, p. 441, doi. 10.1007/s00213-006-0639-1

By:

Braida, Daniela;
Limonta, Valeria;
Pegorini, Simona;
Zani, Alessia;
Guerini-Rocco, Chiara;
Gori, Enzo;
Sala, Mariaelvina

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum : Clinical and Forensic Aspects.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 116, doi. 10.3390/ph14020116

By:

Brito-da-Costa, Andreia Machado;
Dias-da-Silva, Diana;
Gomes, Nelson G. M.;
Dinis-Oliveira, Ricardo Jorge;
Madureira-Carvalho, Áurea;
Mollica, Adriano

Publication type:

Article